Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cost Of Medicare DME, Inpatient Programs On Rise, Scully Tells Appropriators

This article was originally published in The Gray Sheet

Executive Summary

CMS should determine whether costs of "defensive medicine" resulting from the proliferation of medical malpractice lawsuits in the U.S. are increasing Medicare expenditures for beneficiaries, according to Rep. Dave Weldon (R-Fla.)

You may also be interested in...



Scope Of Senate Liability Bill Likely More Narrow Than HR 5 – House Staffer

A medical liability reform law that does not include product liability protection language would spur more lawsuits against device manufacturers, according to Ralph Hall, Guidant general counsel

Scope Of Senate Liability Bill Likely More Narrow Than HR 5 – House Staffer

A medical liability reform law that does not include product liability protection language would spur more lawsuits against device manufacturers, according to Ralph Hall, Guidant general counsel

FDA Product Liability Safeguard Elevated During Consideration Of HEALTH Act

Democratic attempts to challenge the standard of FDA-determined safety as product liability protection were unable to prevent HR 5 from clearing the House Energy & Commerce Committee March 6

Latest Headlines
See All
UsernamePublicRestriction

Register

MT018146

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel